Axillary Lymph Node Status and neoadjuvant Therapy in HER2-positive Breast Carcinoma

被引：0
|
作者：
Danzinger, S. [1 ]
Pfeifer, C. [2 ]
Wimmer, S. [1 ]
Tendl-Schulz, K. [3 ]
Singer, C. F. [1 ]
机构：
[1] Med Univ Wien, Univ Klin Frauenheilkunde, Vienna, Austria
[2] Univ Innsbruck, Inst Stat, Innsbruck, Austria
[3] Med Univ Wien, Klin Inst Pathol, Vienna, Austria
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 04期
关键词：
D O I：
10.1055/s-0043-1766396
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
005
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
    Ida Skarping
    Daniel Förnvik
    Sophia Zackrisson
    Signe Borgquist
    Lisa Rydén
    Breast Cancer Research and Treatment, 2021, 189 : 131 - 144
  • [22] Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
    Skarping, Ida
    Fornvik, Daniel
    Zackrisson, Sophia
    Borgquist, Signe
    Ryden, Lisa
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 131 - 144
  • [23] Axillary Response to Neoadjuvant Therapy in Node-Positive ER-Positive, HER2-Negative Breast Cancer
    Friedman-Eldar, Orli
    Ozmen, Tolga
    Reyes, Fernando Valle
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susane B.
    Moller, Mecker
    Franceschi, Dido
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S236 - S236
  • [24] Prediction of axillary lymph node status in male breast carcinoma
    Vaysse, C.
    Sroussi, J.
    Mallon, P.
    Feron, J-G
    Rivain, A-L
    Ngo, C.
    Belichard, C.
    Lasry, S.
    Pierga, J-Y
    Couturaud, B.
    Fitoussi, A.
    Laki, F.
    Fourchotte, V.
    Alran, S.
    Kirova, Y. M.
    -Salomon, A. Vincent
    Sastre-Garau, X.
    Sigal-Zafrani, B.
    Rouzier, R.
    Reyal, F.
    CANCER RESEARCH, 2012, 72
  • [25] Prediction of axillary lymph node status in male breast carcinoma
    Vaysse, C.
    Sroussi, J.
    Mallon, P.
    Feron, J. G.
    Rivain, A. L.
    Ngo, C.
    Belichard, C.
    Lasry, S.
    Pierga, J. Y.
    Couturaud, B.
    Fitoussi, A.
    Laki, F.
    Fourchotte, V.
    Alran, S.
    Kirova, Y.
    Vincent-Salomon, A.
    Sastre-Garau, X.
    Sigal-Zafrani, B.
    Rouzier, R.
    Reyal, F.
    ANNALS OF ONCOLOGY, 2013, 24 (02) : 370 - 376
  • [26] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [27] The effect of Neoadjuvant Chemotherapy in reducing the need for axillary lymph node dissection in HR+/HER2-node positive breast cancers
    Jabbal, Iktej Singh
    Saravia, Diana
    Yaghi, Marita
    Bilani, Nadeem
    Elson, Leah
    Liang, Hong
    Nahleh, Zeina
    CANCER RESEARCH, 2022, 82 (04)
  • [28] Neoadjuvant therapy for triple negative and HER2-positive early breast cancer
    Harbeck, Nadia
    Gluz, Oleg
    BREAST, 2017, 34 : S99 - S103
  • [29] HER2-positive/ER-low breast carcinoma shows a response to neoadjuvant chemotherapy similar to that of HER2-positive/ER-negative breast carcinoma
    Weisman, Paul
    Ospina-Romero, Monica
    Yu, Qiqi
    Wisinski, Kari
    Xu, Jin
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [30] Advances in neoadjuvant therapy for HER2-positive breast cancers: a narrative review
    Wang, Qianmu
    Wang, Xiaojuan
    Yang, Yanping
    GLAND SURGERY, 2022, 11 (08) : 1415 - 1423
12345